腾博会官网·[中国]-诚信为本,专业服务!

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

ADJUSTMENT TO CONVERSION PRICE OF THE BONDS

POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 5 JUNE 2024

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2024

VOLUNTARY ANNOUNCEMENT - POSITIVE RESULTS ON PHASE III STUDY OF BENMELSTOBART INJECTION IN COMBINATION WITH ANLOTINIB HYDROCHLORIDE CAPSULES FOR FIRST-LINE TREATMENT OF ADVANCED RENAL CELL CARCINOMA

NEXT DAY DISCLOSURE RETURN

VOLUNTARY ANNOUNCEMENT - APPROVAL FOR MARKETING OF CATEGORY 1 INNOVATIVE DRUG BENMELSTOBART INJECTION "BENMELSTOBART (TQB2450)" IN COMBINATION WITH ANLOTINIB HYDROCHLORIDE CAPSULES FOR THE INDICATION OF FIRST-LINE TREATMENT FOR SMALL CELL LUNG CANCER

IMPLEMENTATION OF SHARE INCENTIVE SCHEME BY CHIA TAI TIANQING